GENERAL SESSIONS 9:15 am – 9:30 am Welcome Remarks from PCMA’s President & Chief Executive Officer JC Scott, President & Chief Executive Officer, PCMA 9:30 am – 10:00 am Keynote Address from PCMA’s Incoming Chairman of the Board William Fleming, PharmD, President, Pharmacy Solutions, and Chief Corporate Affairs Officer, Humana Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips 10:00 am – 10:45 am The Power of Partnerships: Changing the Disease Prevention and Total Cost of Care Paradigm Steve Miller, MD, Chief Clinical Officer, Cigna Doug Langa, Executive Vice President North America Operations and President, Novo Nordisk Inc. Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips 10:45 am – 11:15 am ICER Analytics: Will it be the Rosetta Stone for PBM-industry discussions of value? Steve Pearson, MD, Founder & President, Institute for Clinical and Economic Review Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips 11:15 am – 12:00 pm Specialty Cost Trends and Biosimilars: Responding to Payer Cost Concerns and Rewarding Biopharmaceutical Innovation Amy Bricker, President, Express Scripts Heather Cianfrocco, Chief Executive Officer, OptumRx Murdo Gordon, Executive Vice President, Global Commercial Operations, Amgen Moderator: Ian Spatz, Senior Advisor, Manatt Health, Manatt, Phelps & Phillips |